Abstract:Diabetes progression is characterized by loss of functional β-cell mass. Non-obese KATP-GOF mouse models of human neonatal diabetes developed severe diabetes due to lack of insulin secretion; with a marked loss of β-cell mass/identity and dedifferentiation as diabetes progresses. Intermittent fasting (IF) reduces body weight, improves diabetes and autophagy in humans and obese mice, but the mechanisms underlying this in lean individuals remains elusive. Upon diabetes development, non-obese KATP-GOF mice were divided in two groups: i) fed chow diet ad libitum (AL) , ii) subjected to IF (24h fast/24hr feed cycles) . IF-KATP-GOF mice showed reduced blood glucose without changes in body weight or lean-fat mass compared to AL-KATP-GOF mice. The markedly reduced insulin and increased proinsulin levels in islets from AL-KATP-GOF mice were restored to normal levels in IF-KATP-GOF islets. IF-KATP-GOF islets showed reduced ATF6 and sXBP1 message levels and decreased sXBP1 and TXNIP protein levels compared to AL-KATP-GOF islets, suggesting reduced oxidative and ER stress. Strikingly, the markedly increased autophagy markers LC3II and P62 in AL-KATP-GOF islets were reduced to control levels in IF-KATP-GOF, suggesting improved autophagy. Electron microscopy confirmed increased insulin granules, reduced mitochondrial and ER damage, and decreased autophagosome accumulation in IF-KATP-GOF. While liver G6PC and PCK1 (gluconeogenesis) , FAS (lypogenesis/lipolysis) , and CPT1 and ATGL (β-oxidation/lipolysis) messages were increased, CRCT2 and FOXO1 (gluconeogenesis) , GCK (glycolysis) and PPARα (β-oxidation) were decreased. PPARγ and PPARα were decreased in brown adipose tissue. In conclusion, our studies in KATP-GOF mice indicate the beneficial effects of IF not only on improving functional β-cell mass through decreasing oxidative and ER stress and enhancing autophagy, but also improving liver and adipose tissue function. Disclosure E.Castelblanco: None. Z.A.Shyr: None. Z.Yan: None. A.Diwan: Consultant; Biomedical systems (ERT) , Dewpoint Therapeutics. M.S.Remedi: None. Funding National Institutes of Health (GDK123163)

Hepatic Suppression of Mitochondrial Complex II Assembly Drives Systemic Metabolic Benefits

Alternate Day Fasting Improves Endothelial Function in Type 2 Diabetic Mice: Role of Adipose-Derived Hormones

Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: roles of FGF21 and bile acids

Alternate-day fasting prevents non-alcoholic fatty liver disease and working memory impairment in diet-induced obese mice

Intermittent Fasting Promotes Adipocyte Mitochondrial Fusion Through Sirt3-mediated Deacetylation of Mdh2.

Intermittent fasting activates macrophage migration inhibitory factor and alleviates high-fat diet-induced nonalcoholic fatty liver disease

Health Effects of Alternate Day Fasting Versus Pair-Fed Caloric Restriction in Diet-Induced Obese C57Bl/6J Male Mice

Intermittent fasting improves glucose homeostasis not entirely dependent on caloric restriction in db/db male mice

Loss of SDHB Reprograms Energy Metabolisms and Inhibits High Fat Diet Induced Metabolic Syndromes

Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease

Abstract 043: Endothelial Adenosine Kinase Deficiency Ameliorates Diet-induced Insulin Resistance

Influence of intermittent fasting on autophagy in the liver

Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling

Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction

Intermittent Fasting Improves High-Fat Diet-Induced Obesity Cardiomyopathy via Alleviating Lipid Deposition and Apoptosis and Decreasing m6A Methylation in the Heart

318-OR: Intermittent Fasting Improves ß-cell Function in Nonobese KATP-Induced Neonatal Diabetes through Reduction of Cellular Stress and Enhanced Autophagy

Short-term moderate caloric restriction in a high-fat diet alleviates obesity via AMPK/SIRT1 signaling in white adipocytes and liver

Intermittent Fasting Alleviates Non-Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High-Fat and High-Cholesterol Diet Fed Mice

Efficacy and mechanism of intermittent fasting in metabolic associated fatty liver disease based on ultraperformance liquid chromatography-tandem mass spectrometry

Both prolonged high-fat diet consumption and calorie restriction boost hepatic NAD+ metabolism in mice.

Eliciting the Mitochondrial Unfolded Protein Response by Nicotinamide Adenine Dinucleotide Repletion Reverses Fatty Liver Disease in Mice